Easy method of assessing volume of prostate adenocarcinoma from estimated tumor area: using prostate tissue density to bridge gap between percentage involvement and tumor volume.

نویسندگان

  • Goran Torlakovic
  • Vaneeta K Grover
  • Emina Torlakovic
چکیده

AIM To determine prostate carcinoma tumor volume in routine pathology practice by using prostate tissue density. METHODS Prostate tissue density was determined experimentally by using picnometry in 57 unfixed prostate tissue fragments of different size. The percentage of prostate involvement was converted to tumor volume using the equation V=m/rho (g/mL). Additionally, all tumor foci were outlined in 46 prostates. A high grade component was also designated. The percent of prostate involvement by the tumor and separately by the high-grade component was determined using the fine grid method (0.9 mm resolution) in all cases. Pathologist's estimated square area method was applied for comparison in 27 cases. All tumor foci were evaluated for Gleason grades. RESULTS Prostate tissue density (rho) was 0.98 or approximately 1.0 (g/mL). Quicker estimated square area method was fully comparable to more laborious fine grid method for determination of percent of prostate involvement. The percentage of prostate involvement by the tumor as measured by the grid method was not significantly associated with the Gleason sum of the tumor. However, the total tumor volume that was calculated from the percent tumor involvement, mass of the prostate, and tissue density was positively associated with the Gleason sum (P=0.035, linear-by-linear association). CONCLUSION Our results show that prostate tissue density can be used to determine prostate carcinoma tumor volume in routine pathology practice.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of dosimetric and radiobiological effects of various IMRT techniques regarding to joint volume between target tissue and organs at risk in prostate cancer patients

Background: Intensity-modulated radiotherapy (IMRT) is one of the most usable methods in prostate radiotherapy that is used with different techniques. The aim of this study was to evaluate and compare the dosimetric and radiobiological effects of prostate IMRT techniques regarding to joint volume between the target tissue and organs at risk as a patients anatomical parameter. Methods: This res...

متن کامل

Automatic Segmentation of the Gross Tumor Volume in Prostate Carcinoma Using Fuzzy Clustering in Gallium-68 PSMA PET/CT Scan

Introduction: Modern radiotherapy (RT) techniques allow a highly precise deposition of the radiation dose in tumor. So, high conformal tumor doses can be reached while sparing critical organs at risk. Materials and Methods: This study was conducted in three phases. In the first phase; Fourteen patients with primary or recurrent prostate cancer receive Gallium-...

متن کامل

مقایسه "نسبت PSA به حجم بافت بینابینی" با "دانسیتهPSA" در پیشگویی سرطان پروستات

Introduction: Prostatic specific antigen (PSA) is an excellent tumor marker, but it is not specific for prostate cancer. We evaluated the accuracy of PSA adjusted for transition zone volume calculated by transrectal ultrasonography in predicting prostate cancer in men compared with PSA density. Material and Methods: PSA adjusted for transition zone volume was obtained from 100 patients who u...

متن کامل

p53 Protein Expression and Its Relation to the Apoptotic Index in Prostate Adenocarcinoma

Background: Prostate cancer is one of the most commonly diagnosed cancers in males. Tumor suppressor gene p53 plays an important role in causing cell cycle arrest and allowing apoptosis to proceed. Objective: To investigate the expression of p53 protein and its relation to apoptosis and prostate cancer traditional prognostic indicators. Methods: In this study expression of p53 was examined in p...

متن کامل

p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers

Objective(s): Prostate cancer is the world’s leading cause of cancer and the second cause of cancer-related death in men after lung cancer. Differentiation of prostate adenocarcinoma from benign prostate lesions and hyperplasia sometimes cannot be done on the basis of morphologic findings. Considering the fact that in the prostate adenocarcinoma there is no basal cell layer, basal cell markers ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Croatian medical journal

دوره 46 3  شماره 

صفحات  -

تاریخ انتشار 2005